SONM CIK: 1178697

DNA X, Inc.

  • United States
  • Financials
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
35.7
FY22:
43.6
FY23:
43.8
FY24:
32.2
FY25:
28.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.40
FY22:
10.1
FY23:
12.3
FY24:
7.57
FY25:
15.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
41.1
FY22:
53.7
FY23:
56.0
FY24:
39.7
FY25:
43.9

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
21.0
FY22:
32.1
FY23:
32.1
FY24:
43.7
FY25:
48.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.48
FY22:
1.58
FY23:
1.53
FY24:
1.70
FY25:
2.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.6
FY22:
20.0
FY23:
22.4
FY24:
−5.70
FY25:
−7.96
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
41.1
FY22:
53.7
FY23:
56.0
FY24:
39.7
FY25:
–

All amounts in millions USD Data source:SEC EDGAR